Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-24Clinical Trial Update: A Tailored Polygenic Risk Score for Predicting Progression in Prostate Cancer Under Active Surveillance
A completed clinical trial evaluated a tailored polygenic risk score to predict progression in men with prostate cancer on active surveillan…
-
CLINICAL_TRIALS trial_result · 2026-03-24Clinical Trial Update: Hypo Fractionated Versus Conventional IMRT in Unfavorable Intermediate- and High-Risk Prostate Cancer [NA]
Clinical trial update reporting on completed study comparing hypo-fractionated IMRT versus conventional IMRT for unfavorable intermediate- a…
-
CLINICAL_TRIALS trial_result · 2026-03-20Clinical Trial Update: Active Surveillance With or Without Apalutamide Treatment in Low Risk Prostate Cancer [Phase 2]
This Phase 2 trial evaluated active surveillance with or without apalutamide in men with low-risk prostate cancer and has completed.
-
CLINICAL_TRIALS trial_result · 2026-03-20Clinical Trial Update: Molecular Profiling of MRI-PSMA PET Discordance in Prostate Cancer
This completed clinical trial investigates molecular profiling to understand discordance between MRI and PSMA PET imaging in prostate cancer…
-
CLINICAL_TRIALS trial_result · 2026-03-19Clinical Trial Update: A Real-world Study of Characteristics, Treatment Patterns, and Clinical Outcomes Among Lutetium-177 Vipivotide Tetraxetan Treated Patients
A completed clinical trial provides a real-world analysis of patient characteristics, treatment patterns, and clinical outcomes among prosta…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: PSMA PET/CT-Based Multimodal Model for Predicting Response to First-Line Therapy in mHSPC.
This clinical trial update reports a completed study evaluating a PSMA PET/CT-based multimodal model to predict response to first-line thera…
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: PRE-ProstAtectomy MRI-GuidEd Stereotactic Body RadioTherapy for High-Risk Prostate Cancer Trial (PREPARE SBRT) [NA]
Results for the PREPARE SBRT trial (MRI-guided SBRT before prostatectomy for high-risk prostate cancer) have been posted. The study is curre…
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: Use of a Biodegradable Balloon for the Treatment of Prostate Cancer by Intensity Modulated Radiotherapy (BioPro-RCMI) [NA]
The BioPro-RCMI trial evaluating a biodegradable balloon to enhance intensity-modulated radiotherapy for prostate cancer has been terminated…
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations [Phase 1]
ATV-1601, an investigational therapy, is being studied in a Phase 1 trial for patients with AKT1 E17K-mutant cancers, including breast, cerv…
-
CLINICAL_TRIALS trial_result · 2026-03-13Clinical Trial Update: Hypofractionated Stereotactic Boost in Prostate Cancer [Phase 2]
This is a Phase 2 clinical trial update on hypofractionated stereotactic boost for prostate cancer, and the study has completed.
-
CLINICAL_TRIALS trial_result · 2026-03-13Clinical Trial Update: Neoadjuvant Lu-PSMA Radioligand Therapy and Ipilimumab in Men With Very High-risk Prostate Cancer [Phase 1, Phase 2]
A terminated Phase 1/2 trial assessed neoadjuvant Lu-PSMA radioligand therapy in combination with ipilimumab for men with very high-risk pro…
-
CLINICAL_TRIALS trial_result · 2026-03-13Clinical Trial Update: 99mTc-PSMA-I&S Biodistribution in Patients With Prostate Cancer [EARLY_Phase 1]
An early-phase trial update reports the biodistribution of the 99mTc-PSMA-I&S imaging agent in patients with prostate cancer. Recruitment fo…
-
CLINICAL_TRIALS trial_result · 2026-03-12Clinical Trial Update: Rituximab Neoadjuvant Therapy in Patients With Prostate Cancer Scheduled to Undergo Radical Prostatectomy [EARLY_Phase 1]
This report summarizes results from a Phase 1 trial of rituximab given as neoadjuvant therapy before radical prostatectomy in men with prost…
-
CLINICAL_TRIALS trial_result · 2026-03-11Clinical Trial Update: Effects of Music Therapy on Anxiety and Distress Levels During Radionuclide Treatment in Prostate Cancer Patients [NA]
A completed clinical trial evaluating the effects of music therapy on anxiety and distress during radionuclide treatment in prostate cancer …
-
CLINICAL_TRIALS trial_result · 2026-03-10Clinical Trial Update: A Study of Tazemetostat With Enzalutamide or Abiraterone/Prednisone in Participants With Advanced Prostate Cancer [Phase 1, Phase 2]
A Phase 1/2 study evaluating tazemetostat in combination with enzalutamide or abiraterone/prednisone in advanced/metastatic prostate cancer …
-
CLINICAL_TRIALS trial_result · 2026-03-10Clinical Trial Update: Effect of Control Ventilation, PEEP, and PEEP With ARM in Robot-assisted Radical Prostatectomy [NA]
A completed clinical trial examined the effects of control ventilation, PEEP, and PEEP with ARM during robot-assisted radical prostatectomy …
-
CLINICAL_TRIALS trial_result · 2026-03-09Clinical Trial Update: Michigan Genetic Hereditary Testing (MiGHT) [NA]
The MiGHT hereditary genetic testing trial at the University of Michigan Rogel Cancer Center has completed, evaluating testing across multip…
-
CLINICAL_TRIALS trial_result · 2026-03-09Clinical Trial Update: Humidified Forest Oils for Immune System Recovery in Stage I-III Breast or Prostate Cancer [NA]
A clinical trial evaluating humidified forest oils for immune system recovery in stage I-III breast cancer or prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2026-03-09Clinical Trial Update: Palbociclib in Patients With Metastatic Castration-Resistant Prostate Cancer [Phase 2]
Phase 2 clinical trial update on palbociclib for metastatic castration-resistant prostate cancer; the study is currently active and not recr…
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: Transrectal Tumour Oxygen - US Army [Phase 2]
A Phase 2 clinical trial evaluating transrectal tumour oxygen for prostatic neoplasms has completed.
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: Choices About Genetic Testing And Learning Your Risk With Smart Technology [NA]
A completed Rutgers-led trial evaluated choices about genetic testing and learning cancer risk using smart technology across multiple cancer…
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: Prostate Hypoxia FAZA [NA]
The clinical trial Prostate Hypoxia FAZA for prostate cancer (NCT01567800) sponsored by University Health Network, Toronto has completed. No…
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: Optimizing Active Surveillance in Low-Risk Prostate Cancer: a Pilot Study [NA]
This update reports the completion of a pilot study from the University of Michigan Rogel Cancer Center investigating optimization of active…
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: Abemaciclib Plus Darolutamide in Prostate Cancer That Has Spread After Initial Treatment [Phase 1]
A Phase 1 trial evaluating the safety and early efficacy signals of combining abemaciclib with darolutamide in men with metastatic prostate …
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: NeoAdjuvant Theranostic Lutetium Study: The Nautilus Trial [Phase 1, Phase 2]
This update covers the Nautilus trial, a neoadjuvant lutetium theranostic study for prostate cancer in Phase 1 and Phase 2 that is currently…